Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination

Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination

Abstract Vaccine mediated immune mediated thrombocytopenia (ITP) is exceedingly rare. We present a case of a young female who developed severe refractory ITP with multiple bleeding sites post second dose of COVID‐19 vaccination. She was treated with a combination of romiplostim and mycophenolate mof...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Snigdha Nutalapati, Garima Gupta, Gerhard C. Hildebrandt
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
immune thrombocytopenia
mycophenolate mofetil
romiplostim
SARS‐CoV2 vaccination
Medicine
R
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/1437eade9ac94ff394c89f134275467c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1437eade9ac94ff394c89f134275467c
record_format dspace
spelling oai:doaj.org-article:1437eade9ac94ff394c89f134275467c2021-12-01T06:36:07ZRapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination2050-090410.1002/ccr3.5035https://doaj.org/article/1437eade9ac94ff394c89f134275467c2021-11-01T00:00:00Zhttps://doi.org/10.1002/ccr3.5035https://doaj.org/toc/2050-0904Abstract Vaccine mediated immune mediated thrombocytopenia (ITP) is exceedingly rare. We present a case of a young female who developed severe refractory ITP with multiple bleeding sites post second dose of COVID‐19 vaccination. She was treated with a combination of romiplostim and mycophenolate mofetil that resulted in rapid platelet count recovery.Snigdha NutalapatiGarima GuptaGerhard C. HildebrandtWileyarticleimmune thrombocytopeniamycophenolate mofetilromiplostimSARS‐CoV2 vaccinationMedicineRMedicine (General)R5-920ENClinical Case Reports, Vol 9, Iss 11, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic immune thrombocytopenia
mycophenolate mofetil
romiplostim
SARS‐CoV2 vaccination
Medicine
R
Medicine (General)
R5-920
spellingShingle immune thrombocytopenia
mycophenolate mofetil
romiplostim
SARS‐CoV2 vaccination
Medicine
R
Medicine (General)
R5-920
Snigdha Nutalapati
Garima Gupta
Gerhard C. Hildebrandt
Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
description Abstract Vaccine mediated immune mediated thrombocytopenia (ITP) is exceedingly rare. We present a case of a young female who developed severe refractory ITP with multiple bleeding sites post second dose of COVID‐19 vaccination. She was treated with a combination of romiplostim and mycophenolate mofetil that resulted in rapid platelet count recovery.
format article
author Snigdha Nutalapati
Garima Gupta
Gerhard C. Hildebrandt
author_facet Snigdha Nutalapati
Garima Gupta
Gerhard C. Hildebrandt
author_sort Snigdha Nutalapati
title Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
title_short Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
title_full Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
title_fullStr Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
title_full_unstemmed Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
title_sort rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post covid‐19 vaccination
publisher Wiley
publishDate 2021
url https://doaj.org/article/1437eade9ac94ff394c89f134275467c
work_keys_str_mv AT snigdhanutalapati rapidresponsetomycophenolatemofetilincombinationwithromiplostiminacaseofsevererefractoryimmunethrombocytopeniapostcovid19vaccination
AT garimagupta rapidresponsetomycophenolatemofetilincombinationwithromiplostiminacaseofsevererefractoryimmunethrombocytopeniapostcovid19vaccination
AT gerhardchildebrandt rapidresponsetomycophenolatemofetilincombinationwithromiplostiminacaseofsevererefractoryimmunethrombocytopeniapostcovid19vaccination
_version_ 1718405458478235648

Ejemplares similares